Alpha 2.0
Login Register
» Authors » Cheryl Keech

Cheryl Keech

Explore the profile of Cheryl Keech including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 970
Followers 0
Related Specialties
Allergy & Immunology
General Medicine
Endocrinology
Top 10 Co-Authors
Sonali Kochhar
Joyce S Plested
Nita Patel
Shane Cloney-Clark
Gregory M Glenn
Iksung Cho
Maggie Lewis
Gale Smith
Mingzhu Zhu
Louis Fries
Published In
Vaccine
Metabolism
Lancet Infect Dis
Lancet
N Engl J Med
Affiliations
Soon will be listed here.
Recent Articles
1.
Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus-diphtheria-acellular pertussis vaccine: a randomised, double-blind, phase 2b trial
Keech C, Miller V, Rizzardi B, Hoyle C, Pryor M, Ferrand J, et al.
Lancet . 2023 Mar; 401(10379):843-855. PMID: 36906345
Background: Bordetella pertussis epidemics persist as transmission remains unabated despite high acellular pertussis vaccination rates. BPZE1, a live attenuated intranasal pertussis vaccine, was designed to prevent B pertussis infection and...
2.
Comparison of the safety and immunogenicity of a novel Matrix-M-adjuvanted nanoparticle influenza vaccine with a quadrivalent seasonal influenza vaccine in older adults: a phase 3 randomised controlled trial
Shinde V, Cho I, Plested J, Agrawal S, Fiske J, Cai R, et al.
Lancet Infect Dis . 2021 Sep; 22(1):73-84. PMID: 34563277
Background: Improved seasonal influenza vaccines for older adults that can induce broadly cross-reactive antibodies and enhanced T-cell responses, particularly against A H3N2 viruses, while avoiding egg-adaptive antigenic changes, are needed....
3.
Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
Keech C, Albert G, Cho I, Robertson A, Reed P, Neal S, et al.
N Engl J Med . 2020 Sep; 383(24):2320-2332. PMID: 32877576
Background: NVX-CoV2373 is a recombinant severe acute respiratory syndrome coronavirus 2 (rSARS-CoV-2) nanoparticle vaccine composed of trimeric full-length SARS-CoV-2 spike glycoproteins and Matrix-M1 adjuvant. Methods: We initiated a randomized, placebo-controlled,...
4.
Gestational diabetes mellitus: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data
Kachikis A, Eckert L, Walker C, Oteng-Ntim E, Guggilla R, Gupta M, et al.
Vaccine . 2017 Nov; 35(48 Pt A):6555-6562. PMID: 29150061
No abstract available.
5.
Respiratory distress in the neonate: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data
Sweet L, Keech C, Klein N, Marshall H, Tagbo B, Quine D, et al.
Vaccine . 2017 Nov; 35(48 Pt A):6506-6517. PMID: 29150056
No abstract available.
6.
Stillbirth: Case definition and guidelines for data collection, analysis, and presentation of maternal immunization safety data
Da Silva F, Gonik B, McMillan M, Keech C, Dellicour S, Bhange S, et al.
Vaccine . 2016 Jul; 34(49):6057-6068. PMID: 27431422
No abstract available.
7.
Advances in RSV vaccine research and development - A global agenda
Higgins D, Trujillo C, Keech C
Vaccine . 2016 Apr; 34(26):2870-2875. PMID: 27105562
Respiratory syncytial virus (RSV) is an important cause of viral lower respiratory tract illness in infants and children globally, but no vaccine is currently available to protect these vulnerable populations....
8.
Effects of raloxifene on lipid and lipoprotein levels in postmenopausal osteoporotic women with and without hypertriglyceridemia
Dayspring T, Qu Y, Keech C
Metabolism . 2006 Jun; 55(7):972-9. PMID: 16784972
This post hoc analysis reports the effects of raloxifene on lipids and lipoproteins in 2659 women with either normal (< or =150 mg/dL) or high (>150 mg/dL) triglyceride levels from...